
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $4.4B | $17B | $16.1B | $15.1B | |
Revenue Growth (YoY) | -- | -76.25% | 284.25% | -5.72% | -6.2% | |
Cost of Revenues | -- | $3.8B | $14.5B | $13.2B | $11.9B | |
Gross Profit | -- | $607M | $2.5B | $2.9B | $3.1B | |
Gross Profit Margin | -- | 13.7% | 14.85% | 17.84% | 20.87% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $690M | $2.9B | $2.8B | $2.6B | |
Other Inc / (Exp) | -- | -$85M | -$370M | -$137M | -$16M | |
Operating Expenses | -- | $690M | $2.9B | $2.8B | $2.6B | |
Operating Income | -- | -$83M | -$386M | $90M | $552M | |
Net Interest Expenses | -- | $21M | $94M | $122M | $100M | |
EBT. Incl. Unusual Items | -- | -$189M | -$851M | -$168M | $435M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $40M | $524M | $172M | $184M | |
Net Income to Company | -- | -$229M | -$1.4B | -$340M | $252M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$229M | -$1.4B | -$340M | $252M | |
Basic EPS (Cont. Ops) | -- | -$1.02 | -$6.06 | -$1.48 | $1.09 | |
Diluted EPS (Cont. Ops) | -- | -$1.02 | -$6.06 | -$1.48 | $1.05 | |
Weighted Average Basic Share | -- | $224.4M | $226.7M | $229.2M | $231.5M | |
Weighted Average Diluted Share | -- | $224.4M | $226.7M | $229.2M | $239.1M | |
EBITDA | -- | $188M | $617M | $1.1B | $1.6B | |
EBIT | -- | -$168M | -$757M | -$46M | $535M | |
Revenue (Reported) | -- | $4.4B | $17B | $16.1B | $15.1B | |
Operating Income (Reported) | -- | -$83M | -$386M | $90M | $552M | |
Operating Income (Adjusted) | -- | -$168M | -$757M | -$46M | $535M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.8B | $4.4B | $4.3B | $3.9B | $3.8B | |
Revenue Growth (YoY) | -- | -7.13% | -3.97% | -9.52% | -1.3% | |
Cost of Revenues | $4.3B | $3.8B | $3.6B | $3.1B | $3B | |
Gross Profit | $453M | $607M | $643M | $716M | $825M | |
Gross Profit Margin | 9.5% | 13.7% | 15.11% | 18.6% | 21.71% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $714M | $690M | $783M | $714M | $640M | |
Other Inc / (Exp) | -$129M | -$85M | -$120M | $24M | -$43M | |
Operating Expenses | $714M | $690M | $783M | $714M | $640M | |
Operating Income | -$261M | -$83M | -$140M | $2M | $185M | |
Net Interest Expenses | $14M | $21M | $29M | $30M | $23M | |
EBT. Incl. Unusual Items | -$403M | -$189M | -$288M | -$3M | $118M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $91M | $40M | $450M | $41M | $50M | |
Net Income to Company | -$494M | -- | -$737M | -$45M | $69M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$494M | -$229M | -$737M | -$45M | $69M | |
Basic EPS (Cont. Ops) | -$2.21 | -$1.02 | -$3.24 | -$0.20 | $0.30 | |
Diluted EPS (Cont. Ops) | -$2.21 | -$1.02 | -$3.24 | -$0.20 | $0.28 | |
Weighted Average Basic Share | $223.9M | $224.4M | $227.6M | $230.1M | $231.5M | |
Weighted Average Diluted Share | $223.9M | $224.4M | $227.6M | $230.1M | $241.5M | |
EBITDA | $56M | $188M | $113M | $297M | $444M | |
EBIT | -$389M | -$168M | -$259M | $27M | $141M | |
Revenue (Reported) | $4.8B | $4.4B | $4.3B | $3.9B | $3.8B | |
Operating Income (Reported) | -$261M | -$83M | -$140M | $2M | $185M | |
Operating Income (Adjusted) | -$389M | -$168M | -$259M | $27M | $141M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $19.3B | $18.3B | $17B | $16.1B | $15.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $17.1B | $16.1B | $14.5B | $13.2B | $11.9B | |
Gross Profit | $2.2B | $2.3B | $2.5B | $2.9B | $3.1B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.9B | $2.7B | $2.9B | $2.8B | $2.6B | |
Other Inc / (Exp) | -$789M | -$1.2B | -$373M | -$139M | -$16M | |
Operating Expenses | $2.9B | $2.7B | $2.9B | $2.8B | $2.6B | |
Operating Income | -$718M | -$438M | -$387M | $90M | $552M | |
Net Interest Expenses | $62M | $71M | $95M | $121M | $100M | |
EBT. Incl. Unusual Items | -$1.6B | -$1.7B | -$850M | -$168M | $435M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $252M | $350M | $524M | $171M | $184M | |
Net Income to Company | -- | -- | -$1.4B | -$340M | $252M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1.8B | -$2B | -$1.4B | -$340M | $252M | |
Basic EPS (Cont. Ops) | -$8.12 | -$9.17 | -$6.06 | -$1.49 | $1.09 | |
Diluted EPS (Cont. Ops) | -$8.12 | -$9.17 | -$6.06 | -$1.49 | $1.03 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$123M | -$43M | $619M | $1.1B | $1.6B | |
EBIT | -$1.5B | -$1.6B | -$755M | -$47M | $535M | |
Revenue (Reported) | $19.3B | $18.3B | $17B | $16.1B | $15.1B | |
Operating Income (Reported) | -$718M | -$438M | -$387M | $90M | $552M | |
Operating Income (Adjusted) | -$1.5B | -$1.6B | -$755M | -$47M | $535M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $18.3B | $17B | $16.1B | $15.1B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $16.1B | $14.5B | $13.2B | $11.9B | -- | |
Gross Profit | $2.3B | $2.5B | $2.9B | $3.1B | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $29M | -- | -- | -- | -- | |
Selling, General & Admin | $2.7B | $2.9B | $2.8B | $2.6B | -- | |
Other Inc / (Exp) | -$1.2B | -$373M | -$139M | -$16M | -- | |
Operating Expenses | $2.7B | $2.9B | $2.8B | $2.6B | -- | |
Operating Income | -$438M | -$387M | $90M | $552M | -- | |
Net Interest Expenses | $71M | $95M | $121M | $100M | -- | |
EBT. Incl. Unusual Items | -$1.7B | -$850M | -$168M | $435M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $350M | $524M | $171M | $184M | -- | |
Net Income to Company | -$1.8B | -$1.4B | -$340M | $252M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$2B | -$1.4B | -$340M | $252M | -- | |
Basic EPS (Cont. Ops) | -$9.17 | -$6.06 | -$1.49 | $1.09 | -- | |
Diluted EPS (Cont. Ops) | -$9.17 | -$6.06 | -$1.49 | $1.03 | -- | |
Weighted Average Basic Share | $896.4M | $906.7M | $916.7M | $925.8M | -- | |
Weighted Average Diluted Share | $896.4M | $906.7M | $916.7M | $949.6M | -- | |
EBITDA | -$43M | $619M | $1.1B | $1.6B | -- | |
EBIT | -$1.6B | -$755M | -$47M | $535M | -- | |
Revenue (Reported) | $18.3B | $17B | $16.1B | $15.1B | -- | |
Operating Income (Reported) | -$438M | -$387M | $90M | $552M | -- | |
Operating Income (Adjusted) | -$1.6B | -$755M | -$47M | $535M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $2.1B | $1.8B | $1.6B | $1.8B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $2.3B | $1.5B | $1.6B | $1.3B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $524M | $511M | $513M | $446M | |
Total Current Assets | -- | $6.1B | $5B | $4.7B | $4.6B | |
Property Plant And Equipment | -- | $4.1B | $3.7B | $3.5B | $3.3B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $823M | $812M | $805M | $790M | |
Other Intangibles | -- | $145M | $171M | $188M | $217M | |
Other Long-Term Assets | -- | $375M | $267M | $67M | $162M | |
Total Assets | -- | $13.4B | $11.5B | $10.6B | $10.5B | |
Accounts Payable | -- | $1.6B | $1.8B | $1.4B | $1.4B | |
Accrued Expenses | -- | $1.4B | $895M | $963M | $863M | |
Current Portion Of Long-Term Debt | -- | $96M | $110M | $126M | $129M | |
Current Portion Of Capital Lease Obligations | -- | $374M | $316M | $285M | $274M | |
Other Current Liabilities | -- | -- | $73M | $46M | $29M | |
Total Current Liabilities | -- | $5.1B | $4.9B | $4.6B | $4.3B | |
Long-Term Debt | -- | $3.1B | $3.1B | $3.1B | $3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $10.7B | $10B | $9.5B | $9.1B | |
Common Stock | -- | $4.3B | $4.4B | $4.5B | $4.6B | |
Other Common Equity Adj | -- | -$1.1B | -$1.1B | -$1.1B | -$1.2B | |
Common Equity | -- | $2.6B | $1.4B | $1B | $1.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $94M | $97M | $107M | $113M | |
Total Equity | -- | $2.7B | $1.5B | $1.1B | $1.3B | |
Total Liabilities and Equity | -- | $13.4B | $11.5B | $10.6B | $10.5B | |
Cash and Short Terms | -- | $2.1B | $1.8B | $1.6B | $1.8B | |
Total Debt | -- | $3.2B | $3.2B | $3.2B | $3.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $2.1B | $1.8B | $1.6B | $1.8B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $2.3B | $1.5B | $1.6B | $1.3B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $524M | $511M | $513M | $446M | |
Total Current Assets | -- | $6.1B | $5B | $4.7B | $4.6B | |
Property Plant And Equipment | -- | $4.1B | $3.7B | $3.5B | $3.3B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $823M | $812M | $805M | $790M | |
Other Intangibles | -- | $145M | $171M | $188M | $217M | |
Other Long-Term Assets | -- | $375M | $267M | $67M | $162M | |
Total Assets | -- | $13.4B | $11.5B | $10.6B | $10.5B | |
Accounts Payable | -- | $1.6B | $1.8B | $1.4B | $1.4B | |
Accrued Expenses | -- | $660M | $895M | $963M | $863M | |
Current Portion Of Long-Term Debt | -- | $96M | $110M | $126M | $129M | |
Current Portion Of Capital Lease Obligations | -- | $374M | $316M | $285M | $274M | |
Other Current Liabilities | -- | $22M | $73M | $46M | $29M | |
Total Current Liabilities | -- | $5.1B | $4.9B | $4.6B | $4.3B | |
Long-Term Debt | -- | $3.1B | $3.1B | $3.1B | $3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $10.7B | $10B | $9.5B | $9.1B | |
Common Stock | -- | $4.3B | $4.4B | $4.5B | $4.6B | |
Other Common Equity Adj | -- | -$1.1B | -$1.1B | -$1.1B | -$1.2B | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $94M | $97M | $107M | $113M | |
Total Equity | -- | $2.7B | $1.5B | $1.1B | $1.3B | |
Total Liabilities and Equity | -- | $13.4B | $11.5B | $10.6B | $10.5B | |
Cash and Short Terms | -- | $2.1B | $1.8B | $1.6B | $1.8B | |
Total Debt | -- | $3.2B | $3.2B | $3.2B | $3.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$229M | -$1.4B | -$340M | $252M | |
Depreciation & Amoritzation | -- | $356M | $1.4B | $1.2B | $1B | |
Stock-Based Compensation | -- | $31M | $113M | $95M | $100M | |
Change in Accounts Receivable | -- | -$31M | $664M | $11M | $289M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | $189M | $781M | $454M | $942M | |
Capital Expenditures | -- | $180M | $865M | $651M | $605M | |
Cash Acquisitions | -- | -- | -- | -- | $139M | |
Cash From Investing | -- | -$225M | -$835M | -$553M | -$404M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $494M | -- | |
Long-Term Debt Repaid | -- | -$28M | -$118M | -$644M | -$148M | |
Repurchase of Common Stock | -- | -$3M | -$19M | -$22M | -$138M | |
Other Financing Activities | -- | -$10M | -$4M | $2M | -- | |
Cash From Financing | -- | -$43M | -$141M | -$170M | -$286M | |
Beginning Cash (CF) | -- | $2.2B | $2.2B | $1.9B | $1.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$79M | -$194M | -$269M | $251M | |
Ending Cash (CF) | -- | $2.2B | $1.9B | $1.6B | $1.8B | |
Levered Free Cash Flow | -- | $9M | -$84M | -$197M | $337M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$494M | -- | -$737M | -$45M | $69M | |
Depreciation & Amoritzation | $445M | -- | $372M | $270M | $303M | |
Stock-Based Compensation | $16M | -- | $32M | $23M | $22M | |
Change in Accounts Receivable | -$138M | -- | $17M | $24M | $112M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$328M | -- | $12M | $145M | $581M | |
Capital Expenditures | $180M | -- | $154M | $202M | $240M | |
Cash Acquisitions | -- | -- | -- | -- | $2M | |
Cash From Investing | -$100M | -- | -$136M | -$203M | -$205M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$17M | -- | -$35M | -$541M | -$40M | |
Repurchase of Common Stock | -- | -- | -$2M | -$3M | -$76M | |
Other Financing Activities | $460M | -- | -- | $3M | $2M | |
Cash From Financing | $443M | -- | -$41M | -$47M | -$114M | |
Beginning Cash (CF) | $38M | -- | $2B | $1.7B | $1.5B | |
Foreign Exchange Rate Adjustment | -$3M | -- | $9M | -$32M | $23M | |
Additions / Reductions | $15M | -- | -$165M | -$105M | $261M | |
Ending Cash (CF) | $50M | -- | $1.9B | $1.6B | $1.8B | |
Levered Free Cash Flow | -$508M | -- | -$142M | -$57M | $341M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$1.4B | -$340M | $252M | |
Depreciation & Amoritzation | -- | -- | $1.4B | $1.2B | $1B | |
Stock-Based Compensation | $16M | $55M | $113M | $95M | $100M | |
Change in Accounts Receivable | -- | -- | $664M | $11M | $289M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | $781M | $454M | $942M | |
Capital Expenditures | $180M | $572M | $865M | $651M | $605M | |
Cash Acquisitions | -- | -- | -- | -- | $139M | |
Cash From Investing | -- | -- | -$835M | -$553M | -$404M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$118M | -$644M | -$148M | |
Repurchase of Common Stock | -- | -- | -$19M | -$22M | -$138M | |
Other Financing Activities | -- | -- | -- | $2M | -- | |
Cash From Financing | -- | -- | -$141M | -$170M | -$286M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$194M | -$269M | $251M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -$84M | -$197M | $337M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.8B | -$1.4B | -$340M | $252M | -- | |
Depreciation & Amoritzation | $1.2B | $1.4B | $1.2B | $1B | -- | |
Stock-Based Compensation | $55M | $113M | $95M | $100M | -- | |
Change in Accounts Receivable | -$938M | $664M | $11M | $289M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $209M | $781M | $454M | $942M | -- | |
Capital Expenditures | $572M | $865M | $651M | $605M | -- | |
Cash Acquisitions | -- | -- | -- | $139M | -- | |
Cash From Investing | -$472M | -$835M | -$553M | -$404M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $3B | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$74M | -$118M | -$644M | -$148M | -- | |
Repurchase of Common Stock | -$1M | -$19M | -$22M | -$138M | -- | |
Other Financing Activities | -$491M | -- | $2M | -- | -- | |
Cash From Financing | $2.5B | -$141M | -$170M | -$286M | -- | |
Beginning Cash (CF) | $844M | $8B | $6.5B | $5.7B | -- | |
Foreign Exchange Rate Adjustment | -$19M | -$100M | -$37M | -$16M | -- | |
Additions / Reductions | $2.2B | -$194M | -$269M | $251M | -- | |
Ending Cash (CF) | $3B | $7.7B | $6.2B | $5.9B | -- | |
Levered Free Cash Flow | -$363M | -$84M | -$197M | $337M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.